An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women’s Health Initiative cohort

Author:

Desai Pinkal1ORCID,Wallace Robert2,Anderson Matthew L.3,Howard Barbara V.4,Ray Roberta5,Wu Chunyuan5,Safford Monika1,Martin Lisa W.6,Schlecht Nicolas7,Liu Simin8,Cirillo Dominic2,Jay Allison9,Manson JoAnn E.10,Simon Michael S.11ORCID

Affiliation:

1. Weill Cornell Medical College; New York New York

2. Department of Epidemiology; University of Iowa College of Public Health; Iowa City Iowa

3. Baylor College of Medicine; Houston Texas

4. MedStar Health Research Institute and Georgetown/Howard Universities Center for Clinical and Translational Science; Washington District of Columbia

5. Fred Hutchinson Cancer Research Center; Seattle Washington

6. George Washington University; Washington District of Columbia

7. Albert Einstein College of Medicine; Bronx New York

8. Brown University School of Public Health; Providence Rhode Island

9. St John Providence Hospital; Warren Michigan

10. Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts

11. Department of Oncology; Karmanos Cancer Institute; Wayne State University; Detroit Michigan

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

U.S. Department of Health and Human Services

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference35 articles.

1. National Center for Health Statistics Health, United States, 2010: with special feature on death and dying 2011 www.cdc.gov/nchs/data/hus/hus10.pdf#fig17

2. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines;Mann;Ann. Pharmacother.,2008

3. Isoprenoids as mediators of the biological effects of statins;Liao;J. Clin. Invest.,2002

4. Regulation of the mevalonate pathway;Goldstein;Nature,1990

5. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice;Ajith;Clin. Chim. Acta,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3